Breast cancer research publications

Browse recent breast cancer research publications covering diagnosis, screening, pathology, treatment advances, and clinical research.

Female chemist doing some research.

Publications (last 3 years)

These peer reviewed studies cover advances in breast cancer diagnosis, pathology, screening, treatment, and emerging technologies such as artificial intelligence and genomic analysis.

The publications highlight ongoing research that aims to improve early detection, refine diagnostic accuracy, support clinical decision making, and enhance outcomes for people affected by breast cancer.

Title

Journal

Edition

Date

Authors

A poorly differentiated sarcomatoid breast carcinoma with positivity for melanocytic markers: diagnostic challengesPathology RCPAVol. 58, Supplement 1Feb 2026Da young (Dayna) Song, Nirmala Pathmanathan, Kathleen Merrick
Beauty within the beast: metaplastic breast carcinoma with osteoclast-like giant cellsPathology RCPAVol. 58, Supplement 1Feb 2026Tiana Castillo, Nirmala Pathmanathan, Kate Merrick
Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in AustraliaClinical OncologyTBAJan 2026Andrew Redfern, Elgene Lim, Sunil Lakhani, Nirmala Pathmanathan, Sudarsha Selva-Nayagam, Nicole McCarthy, Belinda Yeo, Benjamin Dessauvagie, Gelareh Farshid
Spatial gene expression at single-cell resolution from histology using deep learning with GHISTNature MethodsNo. 22Sep 2025Xiaohang Fu, Yue Cao, Beilei Bian, Chuhan Wang, Dinny Graham, Nirmala Pathmanathan, Ellis Patrick, Jinman Kim and Jean Yee Hwa Yang
The Impact of the COVID-19 Pandemic on Attendance and Diagnostic Outcomes at Breast Screen Western Sydney, AustraliaArchives of Breast CancerVol. 13, No. 3Aug 2025Katelin Yarde, Tessa Hunt, Kerry Hitos, Aswin Shanmugalingam, Nicholas Ngui, Nirmala Pathmanathan,  Meagan E Brennan
Verification of the BREASTEST assay in an Australian population: A novel liquid biopsy assay measuring lipid biomarkers for early-stage breast cancer screeningJournal of Clinical OncologyVol. 43, No.16 SupplMay 2025David Speakman, Klaus-Peter Adam, Tim Huang, Sanjay Warrier, Corinne Ooi, James French, Elisabeth Elder, Cindy Mak, Mary Rickard, Wendy Vincent, Catherine Poliness, Kuan-Chi Wang, Nirmala Pathmanathan, Bruce Mann, Amani Batarseh, John Hurrell, Fatemeh Vafaee, and Simon Preston
Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and ConsistencyModern PathologyVol. 37, Issue 4Apr 2025Gelareh Farshid, Jane Armes, Benjamin Dessauvagie, Amardeep Gilhotra, Beena Kumar f, 
Hema Mahajan, Ewan Millar, Nirmala Pathmanathan, Cameron Snell
8770 Highly Multiplexed Mapping Of The Ductal Carcinoma In Situ Ecosystem To Predict Disease OutcomeJournal of the Endocrine SocietyVol. 8, Issue Suppl 1Oct 2024G M Wilson , T B Doan , B J Guild , N Pathmanathan , J D Graham
Development and Validation of a HER2-Low Focused Immunohistochemical Scoring System With High-Interobserver Concordance: The Australian HER2-Low Breast Cancer Concordance StudyModern PathologyVol. 37, Issue 8Aug 2024Gelareh Farshida, Jane Armesc, Benjamin Dessauvagied, Amardeep Gilhotrab, Beena Kumarf, Hema Mahajang, Ewan Millarg, Nirmala Pathmanathan, Cameron Snell
Abstract PO4-25-12: Improving HER2 Low Scoring Consistency and Accuracy: Insights from the Australian HER2 Low Concordance Study for Invasive Breast CancerCancer ResearchVol. 84, Issue 9, SupplMay 2024Gelareh Farshid; Beena Kumar; Nirmala Pathmanathan; Hema Mahajan; Ben Dessauvagie; Jane Armes; Cameron Snell; Amardeep Gilhotra
PredictSelect – Identifying breast cancer patients who would benefit from EndoPredict TestingThe BreastVol.74, 103635Apr 2024K.A. Ho, E. Elder, J. Elhindi, N. Ngui, M. Kabir, N. Pathmanathan
The Impact of the COVID-19 pandemic on attendance and diagnostic outcomes at BreastScreen Western SydneyThe BreastVol. 74, 103650Apr 2024K. Yarde, T. Hunt, K. Hitos, A. Shanmugalingam, N. Ngui, N. Pathmanathan, M.E. Brennan
Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancerThe Journal of PathologyVol. 260, Issue 1May 2023Rawan Albusayli, J Dinny Graham, Nirmala Pathmanathan, Muhammad Shaban, Shan E Ahmed Raza, Fayyaz Minhas, Jane E Armes, Nasir Rajpoot
Should low-risk DCIS lose the cancer label? An evidence reviewBreast Cancer Research and TreatmentVol. 199, pp 415-433Apr 2023Tara Ma, Caitlin R. Semsarian, Alexandra Barratt, Lisa Parker, Nirmala Pathmanathan, Brooke Nickel and Katy J. L. Bell
Concordance Between Core Needle Biopsy And Surgical Excision For Breast Cancer Tumor Grade And BiomarkersThe BreastVol. 68, p241Apr 2023Aswin Shanmugalingam, Kerry Hitos, Shrenik Hegde, Ali Al-Mashat, Nirmala Pathmanathan, Senarath Edirimmane, T Michael Hughes, Nicholas Ngui

Related information

Download as PDF Print this page
Top of page